Streeton Catherine L, Zwar Nicholas
Clinical R&D and Medical Affairs, GlaxoSmithKline Biologicals, Australia/New Zealand/Oceania, Melbourne, Victoria, Australia.
J Travel Med. 2006 Nov-Dec;13(6):345-50. doi: 10.1111/j.1708-8305.2006.00069.x.
European studies indicate that up to 67% of travelers traveling abroad participate in activities that put them at risk of exposure to hepatitis B. Australians are increasingly traveling to destinations where hepatitis B is highly endemic, such as Asia, and are likely to have similar levels of involvement in activities with an associated risk of hepatitis B exposure.
A series of annual telephone surveys of approximately 500 randomly selected Australian overseas travelers have been conducted under the auspice of the Travel Health Advisory Group over the years 2001 to 2003. The surveys examined the extent to which travelers seek pretravel health advice, what immunizations they receive and what risks they are exposed to during travel including the risk of hepatitis B and other blood-borne virus acquisition.
In the 2003 survey, 281 (56%) of the 503 people interviewed had visited at least one country with high or medium hepatitis B endemicity on their most recent overseas trip in the past two years. Approximately a third of travelers undertook one or more activities that were considered to be associated with increased risk of potential hepatitis B exposure. Less than half the travelers (46%) had been vaccinated against hepatitis B.
The results have implications for the individual traveler, as well as to the broader community. Infected travelers can be an important source of hepatitis B into their own home communities. Improved advice and clear recommendations for hepatitis B vaccination are needed to avoid infection.
欧洲的研究表明,高达67%的出国旅行者参与的活动使他们面临感染乙型肝炎的风险。澳大利亚人越来越多地前往乙型肝炎高流行地区,如亚洲,他们参与有感染乙型肝炎风险活动的程度可能类似。
在旅行健康咨询小组的支持下,2001年至2003年期间对约500名随机挑选的澳大利亚海外旅行者进行了一系列年度电话调查。这些调查考察了旅行者寻求旅行前健康建议的程度、他们接受的免疫接种以及他们在旅行期间面临的风险,包括感染乙型肝炎和其他血源病毒的风险。
在2003年的调查中,503名受访者中有281人(56%)在过去两年的最近一次海外旅行中访问过至少一个乙型肝炎高流行或中等流行的国家。大约三分之一的旅行者进行了一项或多项被认为与潜在乙型肝炎暴露风险增加相关的活动。不到一半的旅行者(46%)接种了乙型肝炎疫苗。
这些结果对个体旅行者以及更广泛的社区都有影响。受感染的旅行者可能是其本国社区乙型肝炎的重要传染源。需要改进关于乙型肝炎疫苗接种的建议并给出明确的推荐,以避免感染。